PMED — Predictmedix AI Share Price
0.000.00%
Last trade - 00:00- CA$3.76m
- CA$3.76m
- 19
- 12
- 47
- 15
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Jan | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | 0.13 | 0.04 | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.
Directors
- Sheldon Kales PRE (55)
- Rakesh Malhotra CFO (61)
- Rahul Kushwah COO
- Lucas Zimmerman OTH
- Ajit Kumar IND
- Tomas Sipos IND
- Last Annual
- January 31st, 2024
- Last Interim
- October 31st, 2024
- Incorporated
- September 3rd, 1987
- Public Since
- December 20th, 2019
- No. of Employees
- 3
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 150,259,542
- Address
- 3000 - 77 King Street West, TORONTO, M5K 1G8
- Web
- https://predictmedix.com/
- Phone
- +1 6478896916
- Contact
- Lucas Zimmerman
- Auditors
- Kreston GTA LLP
Upcoming Events for PMED
Q1 2025 Predictmedix AI Inc Earnings Release
Q2 2025 Predictmedix AI Inc Earnings Release
Similar to PMED
Abound Energy
Canadian Securities Exchange
American Aires
Canadian Securities Exchange
Beyond Oil
Canadian Securities Exchange
Hillcrest Energy Technologies
Canadian Securities Exchange
Hybrid Power Solutions
Canadian Securities Exchange
FAQ
What is the Predictmedix AI share price?
As of Today at 22:44 UTC, shares in Predictmedix AI are trading at CA$0.03. This share price information is delayed by 15 minutes.
How has the Predictmedix AI share price performed this year?
Shares in Predictmedix AI last closed at CA$0.03 and the price had moved by -16.67% over the past 365 days. In terms of relative price strength the Predictmedix AI share price has underperformed the Toronto Stock Exchange 300 Composite Index by -25.91% over the past year.
What are the analyst and broker recommendations for Predictmedix AI?
There is no consensus recommendation for this security.
Find out moreWhat is the Predictmedix AI dividend yield?
Predictmedix AI does not currently pay a dividend.
Does Predictmedix AI pay a dividend?
Predictmedix AI does not currently pay a dividend.
When does Predictmedix AI next pay dividends?
Predictmedix AI does not currently pay a dividend.
How do I buy Predictmedix AI shares?
To buy shares in Predictmedix AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Predictmedix AI?
As of the previous close price of CA$0.03, shares in Predictmedix AI had a market capitalisation of CA$3.76m.
Where are Predictmedix AI shares listed?
Here are the trading details for Predictmedix AI:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: PMED
What kind of share is Predictmedix AI?
Based on an overall assessment of its quality, value and momentum Predictmedix AI is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Predictmedix AI share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Predictmedix AI share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Predictmedix AI. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -0.59%.
As of the last closing price of CA$0.03, shares in Predictmedix AI were trading +15.87% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Predictmedix AI PE Ratio?
The Predictmedix AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Predictmedix AI?
Predictmedix AI's management team is headed by:
- Sheldon Kales - PRE
- Rakesh Malhotra - CFO
- Rahul Kushwah - COO
- Lucas Zimmerman - OTH
- Ajit Kumar - IND
- Tomas Sipos - IND